Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:22 AM
Ignite Modification Date:
2025-12-25 @ 12:22 AM
NCT ID:
NCT01598558
Eligibility Criteria:
Inclusion Criteria:
* Patients must have a diagnosis of CD20-positive B-cell NHL and a staging 18F FDG PET/CT prior to the 64Cu-DOTA-Rituximab PET/CT
* Patients must understand and voluntarily sign an Informed Consent form after the contents have been fully explained to them
* Patients must be scheduled for rituximab-based therapy
* Patients must be older than 18-year-old
Exclusion Criteria:
* Patients who cannot complete a PET/CT scan
* Pregnant women
* Patients participating in other research protocols will be excluded from this study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01598558
Study Brief:
Protocol Section:
NCT01598558